GlassScriptPhysician profile
Ramin B Ashtiani
NPI 1427004977
$18,603.56
in general payments reported to CMS, 2019-2025
46 companies · $1,218 in 2025
The $1,218 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,434 · 2020: $1,397 · 2021: $8,829 · 2022: $2,097 · 2023: $1,799 · 2024: $1,829 · 2025: $1,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,825 · Education: $21.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,824.85 |
| Education | $21.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $7,597.92 | 2020-2024 | Nexletol |
| Merck Sharp & Dohme LLC | $1,012.29 | 2020-2025 | Verquvo, Winrevair, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $969.12 | 2019-2025 | Jardiance |
| Amgen INC. | $962.16 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $892.08 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $772.72 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $665.21 | 2020-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $597.32 | 2022-2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $553.69 | 2019-2025 | Opsumit, Uptravi |
| Amarin Pharma, INC. | $428.67 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $394.09 | 2019-2024 | Farxiga, Lokelma |
| Pfizer INC. | $384.56 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $346.11 | 2019-2025 | Eliquis, Camzyos |
| United Therapeutics Corporation | $330.11 | 2021-2025 | Tyvaso, Tyvaso |
| Scpharmaceuticals INC. | $232.80 | 2023-2025 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $220.67 | 2022-2025 | |
| Boston Scientific Corporation | $214.98 | 2019-2024 | Latitude Communicator Power Supply |
| Abbott Laboratories | $206.60 | 2021-2024 | Assurity, Aveir, Gallant |
| Regeneron Healthcare Solutions, INC. | $189.73 | 2019-2021 | |
| Novo Nordisk INC | $179.82 | 2020-2025 | Rybelsus, Ozempic |
| Gilead Sciences, INC. | $146.93 | 2019 | |
| Sanofi-Aventis U.S. LLC | $146.35 | 2019-2024 | |
| Lexicon Pharmaceuticals, INC. | $134.25 | 2023-2024 | Inpefa |
| Medtronic, INC. | $123.67 | 2021-2024 | Micra, Corevalve Evolut R |
| Lilly USA, LLC | $112.71 | 2022-2025 | Mounjaro |
| Glaxosmithkline, LLC. | $106.68 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $87.38 | 2023-2024 | Cologuard Collection Kit |
| Philips North America LLC | $85.11 | 2020-2024 | (Am5) Lead Management |
| Kiniksa Pharmaceuticals, LTD. | $74.25 | 2022-2023 | Arcalyst |
| Biotronik INC. | $50.68 | 2022 | |
| Recor Medical INC | $43.62 | 2024 | Paradise Renal Denervation System |
| Mylan Specialty L.P. | $40.22 | 2023-2024 | Yupelri |
| Bardy Diagnostics, INC. | $39.70 | 2021 | |
| Baxter Healthcare | $38.48 | 2022 | |
| Preventice Services, LLC | $27.43 | 2021 | |
| Edwards Lifesciences Corporation | $27.25 | 2022 | |
| Biosense Webster, INC. | $23.52 | 2022 | |
| Emd Serono, INC. | $20.80 | 2021 | |
| Alexion Pharmaceuticals, INC. | $19.14 | 2025 | Ultomiris |
| Ionis Pharmaceuticals, INC. | $17.20 | 2025 | Tryngolza |
| Lundbeck LLC | $16.05 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $15.80 | 2024 | Arcalyst |
| Takeda Pharmaceuticals U.S.A., INC. | $15.64 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.23 | 2023 | Quviviq |
| Alnylam Pharmaceuticals INC. | $13.42 | 2021 | |
| Eisai INC. | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramin Ashtiani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.